Search results
Results from the WOW.Com Content Network
Sorrell v. IMS Health Inc., 564 U.S. 552 (2011), [1] is a United States Supreme Court case in which the Court held that a Vermont statute that restricted the sale, disclosure, and use of records that revealed the prescribing practices of individual doctors violated the First Amendment.
South-Eastern Underwriters Association, 322 U.S. 533 (1944), is a United States Supreme Court case in which the Court held that the Sherman Act, the federal antitrust statute, applied to insurance. To reach this decision, the Court held that insurance could be regulated by the United States Congress under the Commerce Clause, overturning Paul v
In parallel with the state investigation, Sidney Zion also filed a separate civil case against the doctors and the hospital. [17] The civil trial came to a close in 1995 when a Manhattan jury found that the two residents and Libby Zion's primary care doctor contributed to her death by prescribing the wrong drug, and ordered them to pay a total ...
Health insurance industry leaders want the US Department of Justice to prosecute accused UnitedHealthcare CEO assassin Luigi Mangione, saying a federal case against him would be a deterrent for ...
United States against the government's requirement for the accused to prove he is "reasonable." The court also rejected the "bad-apple" argument (holding that the additional burden on the government to prove would allow doctors to escape criminal liability much more easily) by stating that such an argument could be applied to almost all cases.
The Janssen doctors and statisticians now had more complete results from the long-term study of children and adolescents using Risperdal. They confirmed that the claim on the current label that gynecomastia was “rare” (meaning that it occurred in fewer than one-tenth of 1 percent of patients) was understated by a factor of more than 50.
The following are settlements reached with US authorities against pharmaceutical companies to resolve allegations of "off-label" promotion of drugs. Under the Federal Food, Drug, and Cosmetic Act, it is illegal for pharmaceutical companies to promote their products for uses not approved by the Food and Drug Administration (FDA), and corporations that market drugs for off-label indications may ...
The McCarran–Ferguson Act, 15 U.S.C. §§ 1011-1015, is a United States federal law that exempts the business of insurance from most federal regulation, including federal antitrust laws to a limited extent.